CN1074606A - 在轴性近视的治疗中使用m1选择性抗毒蕈碱的吡啶苯并二氮酮的方法 - Google Patents

在轴性近视的治疗中使用m1选择性抗毒蕈碱的吡啶苯并二氮酮的方法 Download PDF

Info

Publication number
CN1074606A
CN1074606A CN93100697A CN93100697A CN1074606A CN 1074606 A CN1074606 A CN 1074606A CN 93100697 A CN93100697 A CN 93100697A CN 93100697 A CN93100697 A CN 93100697A CN 1074606 A CN1074606 A CN 1074606A
Authority
CN
China
Prior art keywords
eye
myopia
receptors
benzodiazepine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93100697A
Other languages
English (en)
Chinese (zh)
Inventor
P·马罗加
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of CN1074606A publication Critical patent/CN1074606A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN93100697A 1992-01-21 1993-01-20 在轴性近视的治疗中使用m1选择性抗毒蕈碱的吡啶苯并二氮酮的方法 Pending CN1074606A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82349592A 1992-01-21 1992-01-21
US823,495 1992-01-21

Publications (1)

Publication Number Publication Date
CN1074606A true CN1074606A (zh) 1993-07-28

Family

ID=25238929

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93100697A Pending CN1074606A (zh) 1992-01-21 1993-01-20 在轴性近视的治疗中使用m1选择性抗毒蕈碱的吡啶苯并二氮酮的方法

Country Status (10)

Country Link
EP (1) EP0556947A1 (2)
JP (1) JPH0742231B2 (2)
CN (1) CN1074606A (2)
AU (1) AU3192393A (2)
CA (1) CA2087510A1 (2)
IL (1) IL104409A0 (2)
MX (1) MX9300250A (2)
TW (1) TW222583B (2)
WO (1) WO1993013777A1 (2)
ZA (2) ZA93374B (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115414357A (zh) * 2022-08-30 2022-12-02 天津医科大学眼科医院 一种酰胺类化合物在制备防治近视的药物中的应用

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122522A (en) * 1989-06-21 1992-06-16 The Trustees Of The University Of Pennsylvania Treatment and control of ocular development
AU5312198A (en) * 1997-01-06 1998-08-03 Klaus Trier Aps Screening method
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
WO2016171282A1 (ja) * 2015-04-24 2016-10-27 学校法人慶應義塾 近視予防剤及び近視進行抑制剤
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
CN110320676A (zh) 2015-09-15 2019-10-11 星欧光学股份有限公司 隐形眼镜产品
US10845622B2 (en) 2015-09-15 2020-11-24 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
US12298602B2 (en) 2015-09-15 2025-05-13 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212742B (it) * 1983-05-17 1989-11-30 Dompe Farmaceutici Spa Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica
ES2159661T3 (es) * 1989-06-21 2001-10-16 Univ Pennsylvania Utilizacion de un antagonista muscarinico para la preparacion de un medicamento para el tratamiento y control del desarrollo ocular.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115414357A (zh) * 2022-08-30 2022-12-02 天津医科大学眼科医院 一种酰胺类化合物在制备防治近视的药物中的应用
CN115414357B (zh) * 2022-08-30 2023-09-22 天津医科大学眼科医院 一种酰胺类化合物在制备防治近视的药物中的应用

Also Published As

Publication number Publication date
TW222583B (2) 1994-04-21
AU3192393A (en) 1993-07-22
CA2087510A1 (en) 1993-07-22
JPH0742231B2 (ja) 1995-05-10
EP0556947A1 (en) 1993-08-25
JPH06206820A (ja) 1994-07-26
ZA93384B (en) 1993-08-23
IL104409A0 (en) 1993-05-13
ZA93374B (en) 1993-08-23
MX9300250A (es) 1993-07-01
WO1993013777A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
EP1100480B1 (en) Muscarinic antagonists in the treatment of presbyopia
JP2741624B2 (ja) 眼の発達に対する薬理学的治療法
CN1074606A (zh) 在轴性近视的治疗中使用m1选择性抗毒蕈碱的吡啶苯并二氮酮的方法
KR0147838B1 (ko) 안구 발육의 치료 및 조절
WO2022228546A1 (zh) 用于治疗近视的方法和药物组合物
TW202220664A (zh) 治療近視、預防近視及/或抑制近視進展之藥劑
JP3461778B2 (ja) 眼の発達の治療及び制御
JPH078805B2 (ja) 眼の発育の神経ペプチド制御
CN111349036B (zh) 一种格隆溴铵的替代物及其制备方法和医药用途
Vale et al. Drugs and the Eye: Sponsored by the British Optical Association
AU677860B2 (en) Composition for prophylaxis and treatment of myopia
JP3066561B2 (ja) 近視予防・治療剤
KR980008226A (ko) 시각기능장애의 예방 및 치료제
JP7659940B2 (ja) ビンポセチンを用いる近視の治療方法
JP2002522525A (ja) 視力および記憶障害のための複素環チオエステルまたはケトン
JP7579027B2 (ja) セスキテルペンラクトン系化合物の視神経炎治療薬の製造における使用
JPH10203982A (ja) 視機能障害の予防・治療剤
EP4635495A1 (en) Use of naphthylurea compounds in preparation of drugs for treating pterygium
SWAN et al. Di-N-Butylcarbaminoylcholine sulfate: A new cycloplegic and mydriatic drug
WO2025043297A1 (en) Method of treating myopia
CN119770496A (zh) 一种基于加兰他敏硫辛酸酯的眼科组合物及其应用
JP4708567B2 (ja) Ｎ−複素環化合物のカルボン酸およびカルボン酸アイソスター
JPH0386818A (ja) 白内障予防治療剤
HK1035493B (en) Muscarinic antagonists in the treatment of presbyopia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication